“Comment on ‘Apixaban Vs. Aspirin for Stroke Prevention in People With Subclinical Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack: Subgroup Analysis of the ARTESiA Randomized Controlled Trial’”. Bleeding, Thrombosis and Vascular Biology, vol. 4, no. 2, Apr. 2025, https://doi.org/10.4081/btvb.2025.179.